- Home
- VBNK vs SLP Comparison
VBNK vs SLP Comparison
Compare VBNK & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VBNK
- SLP
- Stock Information
- Founded
- VBNK 1980
- SLP 1996
- Country
- VBNK Canada
- SLP United States
- Employees
- VBNK N/A
- SLP N/A
- Industry
- VBNK Commercial Banks
- SLP EDP Services
- Sector
- VBNK Finance
- SLP Technology
- Exchange
- VBNK Nasdaq
- SLP Nasdaq
- Market Cap
- VBNK 381.8M
- SLP 322.4M
- IPO Year
- VBNK 2021
- SLP 1997
- Fundamental
- Price
- VBNK $12.19
- SLP $16.94
- Analyst Decision
- VBNK Buy
- SLP Buy
- Analyst Count
- VBNK 2
- SLP 8
- Target Price
- VBNK $15.00
- SLP $26.80
- AVG Volume (30 Days)
- VBNK 67.1K
- SLP 442.3K
- Earning Date
- VBNK 12-08-2025
- SLP 12-01-2025
- Dividend Yield
- VBNK 0.59%
- SLP N/A
- EPS Growth
- VBNK N/A
- SLP N/A
- EPS
- VBNK 0.69
- SLP N/A
- Revenue
- VBNK $82,297,771.00
- SLP $80,383,000.00
- Revenue This Year
- VBNK $8.39
- SLP $12.65
- Revenue Next Year
- VBNK $31.45
- SLP $2.92
- P/E Ratio
- VBNK $17.68
- SLP N/A
- Revenue Growth
- VBNK 0.07
- SLP 20.01
- 52 Week Low
- VBNK $8.51
- SLP $12.39
- 52 Week High
- VBNK $18.38
- SLP $37.67
- Technical
- Relative Strength Index (RSI)
- VBNK 55.47
- SLP 54.20
- Support Level
- VBNK $11.76
- SLP $17.28
- Resistance Level
- VBNK $12.17
- SLP $18.95
- Average True Range (ATR)
- VBNK 0.30
- SLP 0.89
- MACD
- VBNK -0.01
- SLP 0.01
- Stochastic Oscillator
- VBNK 51.23
- SLP 47.11
About VBNK VersaBank
VersaBank is a Canadian Schedule I chartered bank with a difference. It has 3 operating segments: Digital Banking Canada, Digital Banking USA and DRTC. It's, cloud-based, business-to-business deposit and lending model provides valued-added solutions to Canadian financial intermediary partners, enabling them to focus on growing their own businesses faster and more profitably. It obtains all of its deposits and provides the majority of its loans and leases electronically, with deposit and lending solutions for financial intermediaries that allow them to excel in their core businesses. In addition, leveraging its internally developed IT security software and capabilities, Company established a wholly owned, subsidiary. Geographically located in Canada and USA.
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.